Skip to main content
SpringerLink
Log in

Design of bioactive compounds

  • Conference paper
  • First Online:
Book cover Medicinal Chemistry

Part of the book series: Topics in Current Chemistry Fortschritte der Chemischen Forschung ((TOPCURRCHEM,volume 52))

  • 385 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ariëns, E. J.: Drug design, Vol. I. New York: Academic Press 1971.

    Google Scholar 

  2. Ariëns, E. J.: Drug design, Vol. II. New York: Academic Press 1971.

    Google Scholar 

  3. Brodie, B. B., Cho, A. K., Krishna, G., Reid, W. D.: Drug metabolism in man: Past, present and future. Ann. N. Y. Acad. Sci. 179, 11 (1971).

    Article  CAS  Google Scholar 

  4. Gillette, J. R.: Comparative metabolism and the choice of experimental animals. In: The laboratory animal in drug testing (ed. A. Spiegel). Stuttgart: Gustav Fischer Verlag 1973.

    Google Scholar 

  5. Miller, J. A., Miller, E. C.: The metabolic activation of carcinogenic aromatic amines and amides. Prog. Exp. Tumor Res. 2, 273 (1969).

    Google Scholar 

  6. Miller, J. A., Miller, E. C.: Chemical carcinogenesis: Mechanisms and approaches to its control. J. Natl. Cancer Inst. 47, V (1971).

    CAS  Google Scholar 

  7. Miller, J. A., Miller, E. C.: Activation of carcinogenic aromatic amines and amides by N-hydroxylation in vivo. In: Carcinogenesis: A broad critique. Proc. 20th Annual Symp. on Fundamental Cancer Research. Houston 1966. Baltimore: Williams & Wilkins 1967.

    Google Scholar 

  8. Miller, E. C., Miller, J. A.: Studies on the mechanism of activation of aromatic amine and amide carcinogens to ultimate carcinogenic electrophilic reactants. Ann. N. Y. Acad. Sci. 163, 731 (1969).

    Article  CAS  Google Scholar 

  9. Miller, E. C., Miller, J. A.: Approaches to the mechanisms and control of chemical carcinogenesis. In: Environment and cancer. Proc. 24th Annual Symp. on Fundamental Cancer Research. Houston 1971. Baltimore: Williams & Wilkins 1972.

    Google Scholar 

  10. Grover, P.: How polycyclic hydrocarbons cause cancer. New Scientist 58, 685 (1973).

    Google Scholar 

  11. Heidelberger, Ch.: Current trends in chemical carcinogenesis. Fed. Proc. 32, 2154 (1973).

    CAS  Google Scholar 

  12. Miller, J. A.: Carcinogenesis by chemicals: An Overview — G. H. A. Clowes Memorial Lecture. 60th Annual Meeting of the Am. Ass. for Cancer Research. San Francisco 1969. Cancer Research 30, 559 (1970).

    CAS  Google Scholar 

  13. Ryser, H. J. P.: Chemical carcinogenesis. New Engl. J. Med. 285, 721 (1971).

    Article  CAS  Google Scholar 

  14. Uehleke, H.: Stoffwechsel von Arzneimitteln als Ursache von Wirkungen, Nebenwirkungen und Toxizität. In: Progress in drug research (ed. E. Jucker), Vol. 15. Basel: Birkhäuser Verlag 1971.

    Google Scholar 

  15. Weisburger, H. H., Weisburger, E. K.: Biochemical Formation and Pharmacological, Toxicological and Pathological Properties of Hydroxylamines and Hydroxamic Acids. Baltimore: Williams & Wilkins 1973.

    Google Scholar 

  16. Peters, R. A.: Biochemical lesions and lethal synthesis. London: Pergamon Press 1963.

    Google Scholar 

  17. Hollaender, A.: Chemical Mutagens, Vol. 1. New York-London: Plenum Press 1971.

    Google Scholar 

  18. Schleiermacher, E., Schroeder, T. M., Adler, I. D., Vrba, M., Vogel, F.: Mutationen durch chemische Einwirkung bei Säuger und Mensch. Dtsch. Med. Wochenschr. 92, 2343 (1967).

    CAS  Google Scholar 

  19. Vogel, F., Krüger, J., Ruhrborn, G., Schleiermacher, E., Schroeder, T. M.: Mutationen durch chemische Einwirkung bei Säuger und Mensch. Dtsch. Med. Wochenschr. 92, 2382 (1967).

    CAS  Google Scholar 

  20. Brodie, B. B., Reid, W. D., Cho, A. K., Sipes, G., Krishna, G., Gillette, J. R.: Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Nat. Acad. Sci. 68, 160 (1971).

    Article  CAS  Google Scholar 

  21. Clegg, D. J.: Teratology. Ann. Rev. Pharmacol. 11, 409 (1971).

    Article  CAS  Google Scholar 

  22. Gillette, J. R., Menard, R. H., Stripp, B.: Active products of fetal drug metabolism. Clin. Pharmacol. Ther. 14, 680 (1973).

    CAS  Google Scholar 

  23. Kleiss, E.: Probleme der Teratogenese. Dtsch. Med. Wochenschr. 92, 1507 (1967).

    CAS  Google Scholar 

  24. Brodie, B. B.: Enzymatic activation of foreign compounds to more potent or more toxic derivatives. In: Abstracts of Invited Presentations, 5th Int. Congr. Pharmacol. San Francisco 1972.

    Google Scholar 

  25. Lewin, R.: Is ageing part of the plan? New Scientist 60, 615 (1973).

    Google Scholar 

  26. Hahn von, H. P.: Primary causes of ageing: a brief review of some modern theories and concepts. Mechanisms of Ageing and Development 2, 245 (1973).

    Article  Google Scholar 

  27. Carr, E. A.: Drug Allergy. Pharmacol. Rev. 6, 365 (1954).

    CAS  Google Scholar 

  28. Parker, Ch. W.: The biochemical basis of an allergic drug response. Ann. N. Y. Acad. Sci. 123, 55 (1965).

    Article  CAS  Google Scholar 

  29. Thoburn, R., Johnson, J. E., Cluff, L. E.: Studies on the epidemiology of adverse drug reactions. JAMA 198, 111 (1966).

    Article  Google Scholar 

  30. Baer, R. L., Harber, L. C.: Photosensitivity induced by drugs. JAMA 192, 989 (1965).

    CAS  Google Scholar 

  31. Jansen, L. H.: Contact sensitivity to simple chemicals: The role of intermediates in the process of sensitization. Naturwissenschaften 51, 387 (1964).

    Article  CAS  Google Scholar 

  32. Reid, W. D., Christie, B., Krishna, G., Mitchell, J. R., Moskowitz, J., Brodie, B. B.: Bromobenzene metabolism and hepatic necrosis. Pharmacology 6, 41 (1971).

    CAS  Google Scholar 

  33. Mitchell, J. R., Jollow, D. J., Gillette, J. R., Brodie, B. B.: Drug metabolism as a cause of drug toxicity. Drug Metabolism and Disposition 1, 418 (1973).

    CAS  Google Scholar 

  34. Reid, W. D., Krishna, G.: Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbons. Exp. Mol. Pathol. 18, 80 (1973).

    Article  CAS  Google Scholar 

  35. Gillette, J. R., Menard, R. H., Stripp, B.: Active products of fetal drug metabolism. Clin. Pharmacol. Ther. 14, 680 (1973).

    CAS  Google Scholar 

  36. Prescott, L. F., Swainson, C. P., Forrest, A. R. W., Newton, R. W., Wright, N., Matthew, H.: Successful Treatment of severe paracetamol overdosage with cysteamine. The Lancet I, 588 (1974).

    Article  Google Scholar 

  37. Ippen, H.: Mechanisms of photoallergic and phototoxic skin reactions. In: Research progress in organic, biological and medicinal chemistry, Vol. III, Part 2, (eds. U. Gallo and L. Santamaria). Amsterdam: North-Holland Publ. Company 1972.

    Google Scholar 

  38. Rodighiero, G., Musajo, L., Dall'Acqua, F., Marciani, S., Caporale, G., Ciavatta, I.: Mechanism of skin photosensitization by furocoumarins. Photoreactivity of various furocoumarins with native DNA and with ribosomal RNA. Biochim. Biophys. Acta 217, 40 (1970).

    CAS  Google Scholar 

  39. Wacker, A.: Molecular mechanisms of photodynamic compounds. In: Research progress in organic, biological and medicinal chemistry, Vol. III, Part 1, (eds. U. Gallo and L. Santamaria). Amsterdam: North-Holland Publ. Company 1972.

    Google Scholar 

  40. Pathak, M. A.: Photosensitivity to drugs. In: Drugs and enzymes, Vol. 4, (eds. B. B. Brodie, J. R. Gillette). Proc. 2nd Int. Pharmacol. Meeting. Prague 1963.

    Google Scholar 

  41. Ariëns, E. J.: Drug levels in the target tissue and effect. In: Clinical pharmacology and therapeutics. Proc. 2nd. Deer Lodge Conf. on Clinical Pharmacology. Hershey USA) 1973, in press.

    Google Scholar 

  42. Ariëns, E. J.: Drug Action: Target tissue, dose-response relationships, receptors. In: Pharmacology and pharmacokinetics. Proc. Conf. Pharmacokinetics: Problems and Perspectives. Washington 1972. New York: Plenum Publ. Company, in press.

    Google Scholar 

  43. Ariëns, E. J., Simonis, A. M.: Modulation of the bioavailability profile of drugs (bioactive compounds) by molecular manipulation. In: Proc. FEES Special Meeting on Industrial Aspects of Biochemistry. Dublin 1973. Amsterdam: North-Holland Publ. Company, in press.

    Google Scholar 

  44. Castro, J. A., De Ferreyra, E. C., De Castro, C. R., De Fenos, O. M., Sasame, H., Gillette, J. R.: Prevention of carbon tetrachloride-induced necrosis by inhibitors of drug metabolism — Further studies on their mechanism of action. Biochem. Pharmacol. 23, 295 (1974).

    Article  CAS  Google Scholar 

  45. Smolen, V. F., Turrie, B. O., Weigand, W. A.: Drug input optimization: Bioavailability-effected time-optimal control of multiple, simultaneous, pharmacological effects and their interrelationships. J. Pharm. Sci. 61, 1941 (1972).

    Article  CAS  Google Scholar 

  46. Schneller, G. H.: Status report on drug bio-availability. Am. J. Hosp. Pharm. 27, 485 (1970).

    CAS  Google Scholar 

  47. Wagner, J. G.: Biologic availability, determinant factor of therapeutic activity of drugs. Drug Intelligence and Pharmacy 7, 168 (1973).

    Google Scholar 

  48. Dittert, L. W., DiSanto, A. R.: The bioavailability of drug products. J. Am. Pharm. Ass. NS13, 421 (1973).

    Google Scholar 

  49. Ariëns, E. J.: Molecular pharmacology, a basis of drug design. In: Progress in drug research, Vol. 10, (ed. E. Jucker). Basel: Birkhäuser Verlag 1966.

    Google Scholar 

  50. Ariëns, E. J.: Drug design — Possibilities and limitations. Chimia 26, 355 (1972).

    Google Scholar 

  51. Ariëns, E. J.: A molecular approach to the modulation of pharmacokinetics: Modification of metabolic conversion by molecular manipulation. Pure and Applied Chemistry 19, 187 (1969).

    Article  Google Scholar 

  52. Hansch, C.: Quantitative structure — Activity relationships in drug design. In: Drug design, Vol. I, (ed. E. J. Ariëns). New York: Academic Press 1971.

    Google Scholar 

  53. Hansch, C., Dunn, W. J.: Linear relationships between lipophilic character and biological activity of drugs. J. Pharm. Sci. 61, 1 (1972).

    Article  CAS  Google Scholar 

  54. Hansch, C., Clayton, J. M.: Lipophilic character and biological activity of drugs II: The parabolic case. J. Pharm. Sci. 62, 1 (1973).

    Article  CAS  Google Scholar 

  55. Leo, A., Hansch, C., Elkins, D.: Partition coefficients and their uses. Chem. Rev. 71, 525 (1971).

    Article  CAS  Google Scholar 

  56. Lien, E. J.: Structure-absorption-distribution relationships: Their significance for drug design. In: Drug design, Vol. V, (ed. E. J. Ariëns). New York: Academic Press, in press.

    Google Scholar 

  57. Bücher, Th., Sies, H.: Inhibitors: Tools in cell research. Berlin-Heidelberg-New York: Springer 1969.

    Google Scholar 

  58. Hochster, R. M., Quastel, J. H.: Metabolic inhibitors, Vols. I–IV. New York: Academic Press 1963–1973.

    Google Scholar 

  59. Martin, G. J.: Biological antagonism. Philadelphia: Blakiston 1951.

    Google Scholar 

  60. Rhoads, C. P.: Antimetabolites and cancer. London: Bailey Bros. & Swinfen Ltd. 1955.

    Google Scholar 

  61. Webb, J. L.: Enzyme and metabolic inhibitors, Vols. I–III. New York: Academic Press 1963, 1966.

    Google Scholar 

  62. Wolstenholme, G. E. W., O'Connor, C. M.: Ciba Foundation Symposium on Amino Acids and Peptides with Antimetabolic Activity. London: J. & A. Churchill Ltd. 1958.

    Google Scholar 

  63. Wooley, D. W.: A study of antimetabolites. New York: Wiley 1952.

    Google Scholar 

  64. Langen, P.: Antimetabolite des Nucleinsäure-Stoffwechsels. Berlin: Akademie-Verlag 1968.

    Google Scholar 

  65. Balis, M. E.: Antagonists and nucleic acids. Amsterdam: North-Holland Publ. Company 1968.

    Google Scholar 

  66. Varley, A. B.: The generic inequivalence of drugs. JAMA 206, 1745 (1968).

    Article  CAS  Google Scholar 

  67. Levy, G.: The therapeutic implications of brand interchange. Am. J. Hosp. Pharm. 17, 756 (1960).

    Google Scholar 

  68. Ariëns, E. J.: Molecular pharmacology, Vol. I. New York: Academic Press 1964.

    Google Scholar 

  69. Baker, B. R.: Design of active-site-directed irreversible enzyme inhibitors. New York: Wiley 1967.

    Google Scholar 

  70. Baker, B. R.: Factors in the design of active-site-directed irreversible inhibitors. J. Pharm. Sci. 53, 347 (1964).

    Article  CAS  Google Scholar 

  71. Baker, B. R.: Specific irreversible enzyme inhibitors. Ann. Rev. Pharmacol. 10, 35 (1970).

    Article  CAS  Google Scholar 

  72. Baker, B. R.: Metabolite antagonism by enzyme inhibition. In: Medicinal chemistry, Vol. I. (ed. A. Burger). New York: Wiley 1970.

    Google Scholar 

  73. Kollonitsch, J., Barash, L., Kahan, F. M., Kropp, H.: New antibacterial agent via photofluorination of a bacterial cell wall constituent. Nature 243, 346 (1973).

    Article  CAS  Google Scholar 

  74. Post, L. C., Vincent, W. R.: A new insecticide inhibits chitin synthesis. Naturwissenschaften 60, 431 (1973).

    Article  CAS  Google Scholar 

  75. Editorial: Worms' enzyme differences exploited by chemotherapists. New Scientist 56, 685 (1972).

    Google Scholar 

  76. Sanderson, B. E.: Anthelmintics in the study of helminth metabolism. In: Chemotherapeutic agents in the study of Parasites. Symp. Brit. Soc. Parasitology, Vol. 11, (eds. A. E. R. Taylor and R. Miller) 1973.

    Google Scholar 

  77. Hitchings, G. H.: Antimetabolites and Chemotherapy: Integration of biochemistry and molecular manipulation. In: Chemotherapy of cancer. (ed. P. A. Plattner). Amsterdam: Elsevier 1964.

    Google Scholar 

  78. Gale, E. F.: Perspectives in chemotherapy. Brit. Med. J. 4, 33 (1973).

    CAS  Google Scholar 

  79. Dietschy, J. M. Wilson, J. D.: Regulation of cholesterol metabolism. New Engl. J. Med. 282, 1128 (1970).

    Article  CAS  Google Scholar 

  80. Gaunt, R., Steinetz, B. G., Chart, J. J.: Pharmacologic alteration of steroid hormone functions. Clin. Pharmacol. Ther. 9, 657 (1968).

    CAS  Google Scholar 

  81. Sobels, F. H.: Chemical mutagenesis and problems involved in the evaluation of environmental mutagens. In: Toxicology: Review and prospect, Vol. XIV. Proc. Eur. Soc. for the Study of Drug Toxicity, Utrecht 1972, (ed. W. A. M. Duncan). Amsterdam: Excerpta Medica 1973.

    Google Scholar 

  82. Tuchmann-Duplesis, H.: Drug teratogenicity. In: Toxicology: Review and prospect, Vol. XIV. Proc. Eur. Soc. for the Study of Drug Toxicity, Utrecht 1972, (ed. W. A. M. Duncan). Amsterdam: Excerpta Medica 1973.

    Google Scholar 

  83. Loubatières, A.: Utilisation de substances sulfamidées dans le traitement du diabète sucre. Therapie 10, 907 (1955).

    Google Scholar 

  84. Ribes, G., Mariani, M. M., Ribes, G., de Malbosc, H., Chapal, J.: Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. I. Action bêtacytotrope insulino-sécrétrice. Diabetologia 5, 1 (1969).

    Article  Google Scholar 

  85. Loubatières, A., Mariani, M. M.: Pharmacologie. — Étude pharmacologique et pharmacodynamique d'un sulfonylurée hypoglycémiant particulièrement actif, le glybenzyclamide. C. R. Acad. Sci. Paris 265, 643 (1967).

    Google Scholar 

  86. Brodie, B. B.: Of mice, microsomes and man. The Pharmacologist 6, 12 (1964).

    Google Scholar 

  87. Wijngaarden van, I., Soudijn, W.: Difenoxine (R 15 403), the active metabolite of diphenoxylate (R 1132). Arzneim.-Forsch. 22, 513 (1972).

    Google Scholar 

  88. Dvornik, D., Kraml, M., Dubuc, J.: Effect of 22,25-diazacholestanol on synthesis of cholesterol by rat liver homogenates. (29299). Proc. Soc. Exp. Biol. Med. 16, 537 (1964).

    Google Scholar 

  89. O'Brien, R. D.: Effects in plants. In: Toxic phosphorus esters. New York: Academic Press 1960.

    Google Scholar 

  90. Wegler, R., Eue, L.: Herbizide. In: Chemie der Pflanzenschutz-und Schädlingssbekämpfungsmittel, Vol. 2, (ed. R. Wegler). Berlin-Heidelberg-New York: Springer 1970.

    Google Scholar 

  91. Crafts, A. S.: The chemistry and mode of action of herbicides. In: Advances in pest control research, Vol. I, (ed. R. L. Metcalf). New York: Interscience Publ., Inc. 1957.

    Google Scholar 

  92. Röhrborn, G.: Mutations in man and relevant methods for the routine screening of mutagens. In: Toxicology: Review and prospect, Vol. XIV. Proc. Eur. Soc. for the Study of Drug Toxicity, Utrecht 1972, (ed. W. A. M. Duncan). Amsterdam: Excerpta Medica 1973.

    Google Scholar 

  93. Editorial: Mutating bacteria spot carcinogenic chemicals. New Scientist 60, 167 (1973).

    Google Scholar 

  94. Newton, B. A.: Trypanocides as biochemical probes. In: Chemotherapeutic agents in the study of parasites. Symp. Brit. Soc. Parasitology, Vol. 11, (eds. A. E. R. Taylor and R. Muller) 1973.

    Google Scholar 

  95. Boyland, E., Williams, K.: An enzyme catalysing the conjugation of epoxides with glutathione. Biochem. J. 94, 190 (1965).

    CAS  Google Scholar 

  96. Oesch, F.: Mammalian epoxide hydrases: Inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3, 305 (1973).

    CAS  Google Scholar 

  97. Evaluation and testing of drugs for mutagenicity: Principles and problems. Wld. Hlth. Org. techn. Rep. Ser. No. 482. Geneva 1971.

    Google Scholar 

  98. Elion, G. B.: Biochemistry and pharmacology of purine analogues. Fed Proc. 26, 898 (1967).

    CAS  Google Scholar 

  99. Brodie, B. B., Reid, W. D., Cho, A. K. Sipes, G., Krishna, G., Gillette, J. R.: Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Nat. Acad. Sci 68, 160 (1971).

    Article  CAS  Google Scholar 

  100. Editorial: Vitamin C stops carcinogenic chemicals being formed. New Scientist 58, 70 (1973).

    Google Scholar 

  101. Reynolds, E. S., Moslen, M. T.: Liver injury following halothane anesthesia in phenobarbital-pretreated rats. Biochem. Pharmacol. 23, 189 (1974).

    Article  CAS  Google Scholar 

  102. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., Brodie, B. B.: Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. PharmacoL Exp. Ther. 187, 185 (1973).

    CAS  Google Scholar 

  103. Grover, P. L., Sims, P.: K-region epoxides of polycyclic hydrocarbons: Reactions with nucleic acids and polyribonucleotides. Biochem. Pharmacol. 22, 661 (1973).

    Article  CAS  Google Scholar 

  104. Ames, B. N., Sims, P., Grover, P. L.: Epoxides of carcinogenic polycyclic hydrocarbons are frameshift mutagens. Science 176, 47 (1972).

    Article  CAS  Google Scholar 

  105. Uehleke, H., Hellmer, K. H., Tabarelli-Poplawski, S.: Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro. Naunyn-Schmied. Arch. Pharmacol. 279, 39 (1973).

    Article  CAS  Google Scholar 

  106. Levine, B. B.: Immunochemical mechanisms involved in penicillin hypersensitivity in experimental animals and in human beings. Fed. Proc. 24, 45 (1965).

    CAS  Google Scholar 

  107. Kalow, W.: Pharmacogenetics. Heredity and the response to drugs. Philadelphia: W. B. Saunders Company 1962.

    Google Scholar 

  108. Pharmacogenetics. Wld. Hlth. Org. techn. Rep. Ser. No. 524. Geneva 1973.

    Google Scholar 

  109. Evans, D. A. P.: Genetic variations in the acetylation of isoniazid and other drugs. Ann. N. Y. Acad. Sci. 151, 723 (1968).

    CAS  Google Scholar 

  110. Vesell, E. S.: Pharmacogenetics. New Engl. J. Med. 287, 904 (1972).

    Article  CAS  Google Scholar 

  111. Reynolds, H. T.: Research advances in seed and soil treatment with systemic and nonsystemic insecticides. In: Advances in pest control research, Vol. II, (ed. R. L. Metcalf). New York: Interscience Publ., Inc. 1958.

    Google Scholar 

  112. Martin, E. W.: Hazards of medication. Philadelphia: J. B. Lippincott Company 1971.

    Google Scholar 

  113. Ariëns, E. J. Simonis, A. M.: The mechanisms of adverse drug reactions. In: Drug-induced diseases, Vol. 4, (eds. L. Meyler and H. M. Peck). Amsterdam: Excerpta Medica 1972.

    Google Scholar 

  114. Ariëns, E. J.: Reduction, of drug action by drug combination. J. Mondial de Pharmacie 12, 263 (1969).

    Google Scholar 

  115. Ariëns, E. J.: Reduction of drug action by drug combination. In: Progress in drug research, Vol. 14, (ed. E. Jucker). Basel: Birkhäuser Verlag 1970.

    Google Scholar 

  116. Beckett, A. H., Rowland, M.: Urinary excretion kinetics of amphetamine in man. J. Pharm. Pharmacol. 17, 628 (1965).

    CAS  Google Scholar 

  117. Turner, P., Young, J. H., Paterson, J.: Influence of urinary pH on the excretion of tranylcypromine sulphate. Nature 215, 881 (1967).

    Article  CAS  Google Scholar 

  118. Lassen, N. A.: Treatment of severe acute barbiturate poisoning by forced diuresis and alkalinisation of the urine. The Lancet II, 338 (1960).

    Article  Google Scholar 

  119. Bird, A. E., Marshall, A. C.: Correlation of serum binding of penicillins with partition coefficients. Biochem. Pharmacol. 16, 2275 (1967).

    Article  CAS  Google Scholar 

  120. Krieglstein, J.: Zur Plasmaproteinbindung von Arzneimitteln. Klin. Wochenschr. 47, 1125 (1969).

    Article  CAS  Google Scholar 

  121. Struller, T.: Progress in sulfonamide research. Prog. Drug Res. 12, 389 (1968).

    CAS  Google Scholar 

  122. Cymerman Craig, J., Dwyer, F. P., Glazer, A. N., Horning, E. C.: Tertiary Amine Oxide Rearrangements. I. Mechanism. J. Am. Chem. Soc. 83, 1871 (1961).

    Article  Google Scholar 

  123. Thuillier, M. J., Domenjoz, R.: Zur Pharmakologie den intravenösen Kurznarkose mit 2-Methoxy-4-allylphenoxyessigsäure-N,N-diäthylamid (G 29505). Anaesthesist 6, 163 (1957).

    CAS  Google Scholar 

  124. Sigg, E. B., Sigg, T. D., Brinling, J. C.: Autonomic actions of the diethylamide of 2-methoxy-4-allyl-phenoxyacetic acid (G 29505). A Non-Barbiturate Anesthetic. Arch. int. Pharmacodyn. 145, 70 (1963).

    CAS  Google Scholar 

  125. Thienpont, D., Niemegeers, C. J. E.: Propoxate (R 7464): A new potent anaesthetic agent in cold-blooded vertebrates. Nature 205, 1018 (1965).

    Article  Google Scholar 

  126. Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. I., Lenaerts, F. M.: Etomidate, R-(+)-ethyl-1-(α-methyl-benzyl)imidazole-5-carboxylate (R 16659), a potent, short-acting and relatively atoxic intravenous hypnotic agent in rats. Arzneim.-Forsch. 21, 1234 (1971).

    CAS  Google Scholar 

  127. Zaagsma, J.: Symposium “Anaesthetic and neuromuscular blocking drugs”. Chem. Wkbl. 68, 5 (1972).

    Google Scholar 

  128. Pointer, D. J., Wilford, J. B., Bishop, D. C.: Crystal structure of a novel curariform agent. Nature 239, 332 (1972).

    Article  CAS  Google Scholar 

  129. Bolger, L., Brittain, R. T., Jack, D., Jackson, M. R., Martin, L. E., Mills, J., Poynter, D., Tyers, M. B.: Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-[1,2-α]-pyridinium dihalides. Nature 238, 354 (1972).

    Article  CAS  Google Scholar 

  130. Huyser, H. W.: Relation between the structure of detergents and their biological degradation. In: Original lectures. 3rd Int. Congr. of Surface Activity. Cologne. Vol. III. 1960.

    Google Scholar 

  131. Brooks, G. T.: The design of insecticidel chlorohydrocarbon derivatives. In: Drug design, Vol. IV, (ed. E. J. Ariëns). New York: Academic Press 1973.

    Google Scholar 

  132. Holan, G.: Rational design of degradable insecticides. Nature 232, 644 (1971).

    Article  CAS  Google Scholar 

  133. Beckett, A. H.: In: Enzymes and drug action, pp. 15 and 238, (eds. J. L. Mongar and A. V. S. de Reuck). London: Churchill 1962.

    Google Scholar 

  134. Levine, R. M., Clark, B. B.: Relationship between structure, and in vitro metabolism of various esters and amides in human serum. J. Pharmacol. exp. Ther. 113, 272 (1955).

    CAS  Google Scholar 

  135. Thomas, J., Stoker, J. R.: The effect of ortho substitution on the hydrolysis of benzoylcholine. J. Pharm. Pharmacol. 13, 129 (1961).

    CAS  Google Scholar 

  136. Bird, A. E., Nayler, J. H. C.: Design of penicillins. In: drug design Vol. II, (ed. E. J. Ariëns). New York: Academic Press 1971.

    Google Scholar 

  137. Karim, S. M. M., Carter, D. C., Bhana, D., Adaikan Ganesan, P.: Effect of orally administered prostaglandin E2 and its 15-methyl analogues on gastric secretion. Brit Med. J. 1, 143 (1973).

    CAS  Google Scholar 

  138. Amy, J. J., Jackson, D. M., Adaikan Ganesan, P., Karim, S. M. M.: Prostaglandin 15 (R) 15-methyl-E2 methyl ester for suppression of gastric acidity in gravida at term. Brit. Med. J. 4, 208 (1973).

    CAS  Google Scholar 

  139. Weeks, J. R., DuCharme, D. W., Magee, W. E., Miller, W. L.: The biological activity of the (15S)-15-methyl analogs of prostaglandins E2 and F2α. J. Pharmacol. Exp. Ther. 186, 67 (1973).

    CAS  Google Scholar 

  140. Lippmann, W., Seethaler, K.: Oral anti-ulcer activity of a synthetic prostaglandin analogue (9-Oxoprostanoic acid: AY-22, 469). Experientia 29, 993 (1973).

    Article  CAS  Google Scholar 

  141. Robert, A., Nylander, B., Andersson, S.: Marked inhibition of gastric secretion by two prostaglandin analogs given orally to man. Life Sci. 14, 553 (1974).

    Article  Google Scholar 

  142. Wain, R. L.: The behaviour of herbicides in the plant in relation to selectivity. In: The physiology and biochemistry of herbicides, (ed. L. J. Andus). London: Academic Press 1969.

    Google Scholar 

  143. Specifications for identity and purity of food additives. Vol. II: Food colors. Rome: Food and Agriculture Organization of the United Nations 1963.

    Google Scholar 

  144. Specifications for Identity and Purity of Food Additives. Volume I: Antimicrobial preservatives and antioxidants. Rome: Food and Agriculture Organization of the United Nations 1962.

    Google Scholar 

  145. Hansson, E., Schmiterlöw, G. C.: A comparison of the distribution, excretion and metabolism of a tertiary (promethazine) and a quaternary (Aprobit®) phenothiazine compound labelled with S 35. Arch Int. Pharmacodyn. Ther. 131, 309 (1961).

    CAS  Google Scholar 

  146. McIsaac, R. J., Koelle, G. B.: Comparison of the effects of inhibition of external, internal and total acetylcholinesterase upon ganglionic transmission. J. Pharmacol. Exp. Ther. 126, 9 (1959).

    CAS  Google Scholar 

  147. Havel, R. J., Kane, J. P.: Drugs and lipid metabolism. Ann. Rev. Pharmacol. 13, 287 (1973).

    Article  CAS  Google Scholar 

  148. Daehne von, W., Frederiksen, E., Gundersen, E., Lund, F., Mørch, P., Petersen, H. J., Roholt, K., Tybring, L., Godtfredsen, W. O.: Acyloxymethyl esters of ampicillin. J. Med. Chem. 13, 607 (1970).

    Article  CAS  Google Scholar 

  149. Launchbury, A. P.: Some recently introduced drugs. In: Progress in medicinal chemistry Vol. 7, (eds. G. P. Ellis and G. B. West). London: Butterworth 1970.

    Google Scholar 

  150. Naumann, P., Rosin, H.: Zur oralen Carbenicillin-Therapie mit Carindacillin. Dtsch. Med. Wochenschr. 98, 2200 (1973).

    Article  CAS  Google Scholar 

  151. Kawasaki, C.: Modified thiamine compounds. Vitamins and Hormones 21, 69 (1963).

    CAS  Google Scholar 

  152. Wagner, H., Wagner-Hering, E.: Lipophilic thiamine derivatives. Med. Klin. 62, 217 (1967).

    CAS  Google Scholar 

  153. Editorial: Garlic odor removed from new thiamine derivatives. Japan Medical Gazette November 1964.

    Google Scholar 

  154. Mitoma, C.: Metabolic disposition of thiamine tetrahydrofurfuryl disulfide in dog and man. Drug metabolism and Disposition 1, 698 (1973).

    CAS  Google Scholar 

  155. Imai, Y.: The antiscorbutic activity of some O-benzoyl derivatives of L-ascorbic acid in guinea pigs. Chem. Pharm. Bull. 14, 1045 (1966).

    CAS  Google Scholar 

  156. Schlör, H.: II. Spezieller Teil: Chemie der Fungizide. In: Chemie der Pflanzenschutzund Schädlingsbekämpfungsmittel, Vol. 2, (ed. R. Wegler). Berlin-Heidelberg-New York: Springer 1970.

    Google Scholar 

  157. Richardson, A., Walker, H. A., Miller, I., Hansen, R.: Metabolism of methyl and benzyl esters of penicillin by different species. Proc. Exp. Biol. Med. 60, 272 (1945).

    CAS  Google Scholar 

  158. Kingstone, E.: The use of fluphenazine enanthate in an out-patient clinic. Int. J. Clin. Pharmacol. 1, 413 (1968).

    CAS  Google Scholar 

  159. Hirsch, S. R., Gaind, R., Rohde, P. D., Stevens, B. C., Wing, J. K.: Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: Double-blind Placebo Trial. Brit. Med. J. 1, 633 (1973).

    Article  CAS  Google Scholar 

  160. Adema, D. M. M., Meijer, G. M., Hueck, H. J.: The biological activity of pentachlorophenol esters — A preliminary note. Int. Biodetn. Bull. 3, 29 (1967).

    CAS  Google Scholar 

  161. Weck de, A. L.: Immunochemical mechanisms in drug allergy. In: Mechanisms in drug allergy, (eds. C. H. Dash and H. E. H. Jones). Edinburgh-London: Churchill Livingstone 1972.

    Google Scholar 

  162. Rosowsky, A.: Methotrexate analogs. 2. A facile method of preparation of lipophilic derivatives of methotrexate and 3′,5′-dichloromethotrexate by direct esterification. J. Med. Chem. 16, 1190 (1973).

    Article  CAS  Google Scholar 

  163. Johns, D. G., Farquhar, D., Chabner, B. A., Wolpert, M. K., Adamson, R. H.: Antineoplastic activity of lipid-soluble dialkyl esters of methotrexate. Experientia 29, 1104 (1973).

    Article  CAS  Google Scholar 

  164. Sharpe, A.: The physical properties of the carbon-fluorine bond. In: Carbon-fluorine compounds. A Ciba Foundation Symp. Amsterdam: Elsevier-Excerpta Medica 1972.

    Google Scholar 

  165. Brodie, B. B.: Enzyme activation of drugs and other foreign compounds to derivatives that produce tissue lesions. In: Pharmacology and the future of man, Vol. 2. Toxicological Problems. Proc. 5th Int. Congr. Pharmacology. San Francisco 1972. Basel: S. Karger 1973.

    Google Scholar 

  166. Reid, W. D.: Relationship between tissue necrosis and covalent binding of toxic metabolites of halogenated aromatic hydrocarbons. In: Pharmacology and the future of man, Vol. 2. Toxicological Problems. Proc. 5th Int. Congr. Pharmacology. San Francisco 1972. Basel: S. Karger 1973.

    Google Scholar 

  167. Freese, E.: Molecular mechanisms of mutations. In: Chemical mutagens. Principles and methods for their detection Vol. 1, (ed. A. Hollaender). New York: Plenum Press 1971.

    Google Scholar 

  168. Miller, E. C., Miller, J. A.: The mutagenicity of chemical carcinogens: Correlations, problems, and interpretations. In: Chemical mutagens. Principles and methods for their detection Vol. 1, (ed. A. Hollaender). New York: Plenum Press 1971.

    Google Scholar 

  169. Uehleke, H.: Mechanisms of methemoglobin formation by therapeutic and environmental agents. In: Pharmacology and the future of man, Vol. 2. Toxicological problems. Proc. 5th Int. Congr. Pharmacology. San Francisco 1972. Basel: S. Karger 1973.

    Google Scholar 

  170. Poirier, L. A., Weisburger, J. H.: N-Hydroxylation and carcinogenesis. In: Pharmacology and the future of man. Vol. 2. Toxicological Problems. Proc. 5th Int. Congr. Pharmacology. San Francisco 1972. Basel: S. Karger 1973.

    Google Scholar 

  171. Gillette, J. R.: Factors that affect the covalent binding and toxicity of drugs. In: Pharmacology and the future of man, Vol. 2. Toxicological Problems. Proc. 5th Int. Congr. Pharmacology. San Francisco 1972. Basel: S. Karger 1973.

    Google Scholar 

  172. Boyland, E.: The carcinogenic action of oxidation products of aromatic compounds. In: Biochemical aspects of antimetabolites and of drug hydroxylation, Vol. 16. 5th FEBS Symposium. Prague 1968, (ed. D. Shugar). London: Academic Press 1969.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacological Institute, University of Nijmegen, Nijmegen, The Netherlands

    Prof. Dr. Everardus J. Ariëns & Anna-Maria Simonis

Authors
  1. Prof. Dr. Everardus J. Ariëns
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna-Maria Simonis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1974 Springer-Verlag

About this paper

Cite this paper

Ariëns, E.J., Simonis, AM. (1974). Design of bioactive compounds. In: Medicinal Chemistry. Topics in Current Chemistry Fortschritte der Chemischen Forschung, vol 52. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-06873-2_13

Download citation

  • DOI: https://doi.org/10.1007/3-540-06873-2_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-06873-0

  • Online ISBN: 978-3-540-37834-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation